Sivik Global Healthcare »

Ascendis Pharma A S shares owned by Sivik Global Healthcare

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Sivik Global Healthcare from 13F filings

Historical chart of Sivik Global Healthcare investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Sivik Global Healthcare consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Sivik Global Healthcare

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 10k 149.30

More positions owned by Sivik Global Healthcare

Spdr S&p Biotech Etf S&p Biotech (XBI)
Eli Lilly & Co. (LLY)
Tenet Healthcare Com New (THC)
Novo-nordisk A/s Adr (NVO)
Univ Health Svc Class B (UHS)
McKesson Corporation (MCK)
Stryker Corporation (SYK)
Boston Scientific Corporation (BSX)
Intuitive Surg Com New (ISRG)
Danaher Corporation (DHR)
Hca Holdings (HCA)
Surgery Partners (SGRY)
Acadia Healthcare (ACHC)
Abbott Laboratories (ABT)
Avantor (AVTR)

View all positions for Sivik Global Healthcare

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
Artisan Partners Limited Partnership
Henderson Group
T. Rowe Price Associates
Capital Research and Management Company - Division 3
Massachusetts Financial Services
T. Rowe Price Investment Management
Franklin Resources
Invesco
Citadel Advisors
BlackRock
Point72 Asset Management
TimesSquare Capital Management
Brown Advisory Holdings Incorporated

View all funds holding Ascendis Pharma A S